Novartis Investigative Site

Sankt Pölten 3100

0 studies enrolling now · 4 studies all time

What they study most

Acute Myocardial Infarction, Heart Failure With Reduced Ejection Fraction (HF-rEF), Melanoma, Relapsing Forms of Multiple Sclerosis

Studies at this site

• A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma — Stopped early
• Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI — Completed
• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed
• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE